Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

First human test for experimental cholesterol fighter

NCT ID NCT07423598

Summary

This early-stage study is testing a new oral medication called AZD0780 to see if it safely lowers LDL (bad) cholesterol. The trial involves 40 healthy adults who already have elevated cholesterol levels. Participants will take either the experimental drug or a placebo daily for 28 days while researchers monitor cholesterol changes and safety.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Research Site

    RECRUITING

    Brooklyn, Maryland, 21225, United States

Conditions

Explore the condition pages connected to this study.